Lauren K. Meyer, MD, PhD¹, Erica A. Steen^2*, Camille Keenan, MD, MPH^1*, Adam B. Olshen, PhD^3*, Kim E. Nichols, MD⁴ and Matt S. Zinter, MD^3*

¹University of Washington, Seattle, WA
²University of California, San Diego, San Diego, CA
³University of California, San Francisco, San Francisco, CA
⁴St. Jude Children's Research Hospital, Memphis, TN

Dorottya Laczko, MD, PhD^1*, David C. Fajgenbaum, MD, MBA, MSc² and Taku Kambayashi, MD, PhD^1*

¹Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
²Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Melanie Mumau^1*, Abiola Irvine, BS^2*, Chunyu Ma, MSc^3*, Sheila K. Pierson, MSc^1*, Brent Shaw, BS^4*, Michael V. Gonzalez^2*, Daniel Korn, PhD^2*, Tracey Sikora, BS^4*, Grant Mitchell, MD, MBA^4*, David Koslicki, PhD^3*, Luke Y. C. Chen, MD, MEd⁵ and David C. Fajgenbaum, MD, MBA, MSc¹

¹Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
³Penn State University, University Park, PA
⁴Every Cure, Philadelphia, PA
⁵Vancouver General Hospital, Vancouver, BC, CAN

Jin Kyung Suh, MD, PhD^1*, Ho Joon Im, MD, PhD^2*, Sung Han Kang, MD^2*, Hyery Kim, MD², Eun Seok Choi^2* and Kyung-Nam Koh, MD, PhD^2*

¹Department of Pediatrics, Center for Pediatric Cancer, National Cancer Center, Goyang, Korea, Republic of (South)
²Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Xunhong Cao^1*, Ting-Ting Han^2*, Ming Zhao^3*, Xie Juan, MD^4*, Ying-Jun Chang^5,6,7,8*, Xiao-Jun Huang, MD^2* and Xiangyu Zhao, M.D, Ph.D²

¹Institute of Hematology, Peking University People's Hospital, Beijing, AL, China
²Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
³Institute of Hematology, Peking University People's Hospital, Beijing, China
⁴Peking University of People’s Hospital, Beijing, China
⁵Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁶National Clinical Research Center for Hematologic Disease, Beijing, China
⁷Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
⁸Peking University Institute of Hematology, Beijing, China

Diego A Lopez^1*, Aleah Griffin, BS^2*, Robert Welner, PhD³, Lorena Moreno Aguilar, MPH^4*, Cassandra Deering-Rice, PhD^5* and Anna E Beaudin, PhD⁶

¹Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT
²Department of Biomedical Engineering, University of Utah, Salt Lake City, UT
³Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
⁴Department of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles
⁵Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT
⁶Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT

Rui Ma^1*, Zhenlong Li, PhD^1*, Hejun Tang^1*, Lei Tian^1*, Zahir Shah^1*, Tasha Barr^1*, Amy Peng², Jianying Zhang, PhD^1,2*, Srividya Swaminathan, PhD³, Michael A Caligiuri, MD^4,5 and Jianhua Yu, PhD⁶

¹Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, City of Hope National Medical Center, Duarte, CA
²City of Hope National Medical Center, Duarte, CA
³City of Hope - BRC, Duarte, CA
⁴Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA
⁵Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA
⁶Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Yi Liu^1*, Nianci Chen^1*, Yile Zhou, PhD^1*, Li Zhu^2*, Zuopo Lv^1*, Chenying Li^3*, Jiansong Huang, PhD^4*, Yanhong Tong^5*, Haitao Meng^2*, Jie Jin, MD⁴ and Liangshun You, MD^4*

¹The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²Zhejiang University, Hangzhou, CHN
³First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, CHN
⁴Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Moraima Jimenez, MD^1*, Víctor Navarro Garces^2*, Irene Medina^3*, Cristina Andres^4*, Monica Martinez-Gallo^5*, Daniel Medina, MSc, BSc^6,7*, Andres Anton^4*, Adaia Albasanz-Puig^8*, Alba Cabirta Touzón, MD^9,10*, Ana Pérez González, MD^11*, Angel Serna, MD^12,13*, Josu Iraola-Truchuelo^14*, Tomás Pumarola^15*, Manuel Hernandez^5*, Isabel Ruiz Camps^16*, David Valcarcel Ferreiras, PhD^17,18*, Marta Crespo, PhD^6,10*, Juliana Esperalba^15*, Francesc Bosch, MD, PhD^17,19 and Pau Abrisqueta Costa, MD, PhD^13,20*

¹Vall d´Hebron Institute of Oncology, Vall d´Hebron University Hospital, BARCELONA, Spain
²Oncology Data Science (ODysSey), Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain
³Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain, BARCELONA, Spain
⁴Department of Microbiology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain, BARCELONA, Spain
⁵Department of Immunology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Research Institute, Vall d’Hebron Barcelona Hospital Campus. Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UA), Barcelona, Spain., BARCELONA, Spain
⁶Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁷Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain, Bellaterra, Spain
⁸Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain
⁹Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, AL, Spain
¹⁰Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain
¹¹Hematology Department, Vall d'Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
¹²Hematology Department,, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹³University Hospital Vall d’Hebron, Barcelona, Spain
¹⁴Vall d'Hebron University Hospital, Barcelona, Spain
¹⁵Department of Microbiology, Vall D'Hebron Hospital Universitari, Vall D'Hebron I, Barcelona, ESP
¹⁶Department of Infectious Diseases, Vall D'Hebron Hospital Universitari, Vall D'H, Barcelona, ESP
¹⁷Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹⁸Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, University Autonoma of Barcelona (UAB), Barcelona, Spain
¹⁹Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
²⁰Department of Hematology, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Yinghua Wang, BSc^1*, Xuan Pan, PhD, DVM¹, Mei Yu, PhD^2* and Renren Wen, PhD²

¹University of Wisconsin Madison, Madison, WI
²Versiti Blood Research Institute, Milwaukee, WI

Li Jun, MD^1*, Yi Liu^1*, Xia Wei^2*, Zhanshu Liu, MD^3*, Zailiang Yang, MD^4*, Ling Liu^5*, Meiyu Zhou^4*, Guofa Xu, MD^4*, Lanting Chen^3*, Yao Ding^1*, Haike Lei^6*, Qiying Li^1*, Yingyu Nan^1*, Jieping Li^1*, Yong Zhang, MD, PhD^2*, Yongzhong Wu, MD, PhD^7* and Yao Liu, PhD, MD¹

¹Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
²Department of Hematology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing, China
³Department of Hematology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China
⁴Department of Hematology and Medical Oncology, Chongqing University Fuling Hospital, Chongqing, China
⁵Department of Medical Laboratory, People’s Hospital of Chongqing Liang Jiang New Area, Chongqing, China
⁶Department of Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing, China
⁷Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China

Angelos-Michael Papadopoulos^1*, Anastasia Iatrou^2*, Apostolos Axenopoulos^1*, Andreas Agathangelidis^2,3*, Kostas Stamatopoulos² and Petros Daras^1*

¹Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece
²Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
³School of Biology, National and Kapodistrian University of Athens, Athens, Greece

Guoping Fu^1*, Yongwei Zheng, PhD^1*, Gang Xin, PhD^2*, Zhengqi Wang, PhD^3*, Kevin D. Bunting, PhD³, Weiguo Cui, PhD^4*, Arthur Salomon, PhD^5* and Renren Wen, PhD^1,6

¹Versiti Blood Research Institute, Milwaukee, WI
²Ohio State University College of Medicine, Columbus
³Emory University School of Medicine, Atlanta, GA
⁴Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
⁵Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence
⁶Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI